ClearPoint Neuro ( (CLPT) ) just unveiled an update.
ClearPoint Neuro reported a strong third quarter in 2024 with a 41% increase in revenue, reaching $8.1 million, and reducing operational cash burn by 33%. The company’s growth was fueled by increased demand for its SmartFrame OR Navigation system and Prism Laser Therapy, along with a significant rise in product revenue. ClearPoint Neuro also repaid a $10 million convertible note, leaving no outstanding debt, and activated five new global centers, enhancing its market presence and potential for future growth.
Learn more about CLPT stock on TipRanks’ Stock Analysis page.
